Dr. Christopher V. Crosby, MD, PhD

Dr. Crosby practices at Grossmont Medical Terrace - O/P Imaging - HOPD in La Mesa, California.

Dr. Crosby's NPI, 1497931380, was assigned on January 10, 2008. Dr. Crosby graduated from Medical University of South Carolina (MUSC) in 2005. Dr. Crosby holds California license A107312.

Dr. Crosby's primary practice is Grossmont Medical Terrace - O/P Imaging - HOPD, at 8860 Center Dr, La Mesa, CA 91942.

Dr. Crosby's primary practice is Grossmont Medical Terrace - O/P Imaging - HOPD in La Mesa, California. The medical group on file is Coastal Skin and Eye Institute. Dmand AI also links Dr. Crosby to 2 more group practices and clinics and 1 medical group, each named with a free account. Dr. Crosby's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Crosby practices, 3 sites in all. Vendor and product names are available with a free account.

Mohs-micrographic surgery is Dr. Crosby's primary specialty in the NPI Registry, under taxonomy code 207ND0101X. Dr. Crosby is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Crosby's licenses on file in 7 states: California, Ohio, Florida, Georgia, Nevada, South Carolina and Washington.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, contact dermatitis, corns and calluses, hives and itchy rashes among the conditions Dr. Crosby treats.

CMS data shows 4,232 Medicare services from Dr. Crosby across 41 procedure codes in 2024, for 829 Medicare patients. Medicare paid $477,067 for them. Every service was in an office.

CMS counts 829 Medicare patients who saw Dr. Crosby in 2024. The largest group is 75 to 84, with 360 patients. 73% of them have high cholesterol, and 68% have high blood pressure. 6% are also on Medicaid. Their average risk score is 1.12, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Crosby's median patient age at 65, with 54% women.

In 2024, Dr. Crosby wrote 334 Medicare Part D claims for 192 patients. 92% of them were for generic drugs. CMS names the drug for 247 of them, across 9 drugs with 11 or more claims each, at $61,632 in total drug cost. In 2023, CMS named 217 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 14 out of 100 for Dr. Crosby for performance year 2024, reported individually. Dr. Crosby accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 123 procedures of melanoma (skin cancer) excision by Dr. Crosby, more than 94% of the clinicians it reports for that procedure.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 4 papers to Dr. Crosby in 2004. Dr. Crosby's most frequent co-author is Michelle Balow Crosby, MD, PhD.

CMS Open Payments shows 254 general payments to Dr. Crosby from 38 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 70% of the total. Genentech, Inc. paid the most, $39,897.

Dmand AI lists 3 awards for Dr. Crosby.

Dr. Crosby graduated from Medical University of South Carolina (MUSC) in 2005. Dr. Crosby is a member of AAD and ASDS.

Dr. Crosby is in network with 12 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.